FINELINE II
Report
- Report Number
- 2124215-2014-17408
- Event Type
- Injury
- Date Received
- October 3, 2014
- Date of Event
- September 16, 2014
- Report Date
- October 14, 2014
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- DTB
- Adverse Event
- Yes
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). THE PRODUCT IS EXPECTED TO BE RETURNED FOR ANALYSIS. THIS REPORT WILL BE UPDATED UPON RETURN AND COMPLETION OF ANALYSIS.
(B)(4). UPON RECEIPT AT OUR POST MARKET QUALITY ASSURANCE LABORATORY, ONLY THE TERMINAL SEGMENT OF THE LEAD WAS RETURNED. VISUAL INSPECTION NOTED BRUISING OF THE SILICONE INSULATION, STRETCHED ANODE AND CATHODE COILS AND CATHODE FRACTURE APPROXIMATELY 25-26 CM FROM THE TERMINAL PIN. DETAILED ANALYSIS OF THE FRACTURE SITE DETERMINED THE CONDUCTOR COIL WAS FRACTURED DUE TO LOCALIZED COMPRESSIVE STRESS ON THE TUBING SURFACE. THE LOCATION OF THE DAMAGE SITE SUGGESTS THE FRACTURE WAS A RESULT OF CLAVICULAR CRUSH/FIRST RIB ENTRAPMENT. THE REPORTED LOC AND HIGH IMPEDANCE MEASUREMENTS ARE LIKELY THE RESULT OF THE LEAD DAMAGE OBSERVED BY THE LABORATORY.
ADDITIONAL INFORMATION WAS RECEIVED INDICATING THE PATIENT IS VERY ACTIVE PERFORMING HANDYMAN AND HOME RENOVATION ACTIVITIES WHICH ARE SUSPECTED TO HAVE CONTRIBUTED TO THE REPORTED LEAD DAMAGE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.
BOSTON SCIENTIFIC RECEIVED INFORMATION THAT THIS RIGHT VENTRICULAR (RV) LEAD EXHIBITED LOSS OF CAPTURE (LOC) AND HIGH OUT-OF-RANGE PACE IMPEDANCE MEASUREMENTS UPON THE PATIENT'S PRESENTATION TO THEIR CLINIC FOR DISCOMFORT. THE PATIENT WAS NOTED TO BE ATRIAL FIBRILLATION (AF) WITH SLOW VENTRICULAR ESCAPE RHYTHM AT THE TIME OF THEIR PRESENTATION. AN X-RAY WAS OBTAINED INDICATING A LEAD CONDUCTOR FRACTURE NEAR THE CLAVICLE. THE PHYSICIAN ALSO SUSPECTED INSULATION DAMAGE AS THE PATIENT WAS REPORTED TO EXPERIENCE PECTORAL STIMULATION. A REVISION PROCEDURE WAS PERFORMED WHEREUPON THE LEAD SUSTAINED DAMAGE DURING THE EXTRACTION PROCESS RESULTING IN ITS SEVERING. THE LEAD WAS FULLY EXTRACTED AND REPLACED WITH A NEW RV LEAD. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED. THIS LEAD IS NO LONGER IN SERVICE.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 618251 | FINELINE II | IMPLANTABLE LEAD | DTB | CPI - DEL CARIBE | 4459 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Hospitalization| L| R | 4459| J276| 4473| 7742 |